Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05058495
Other study ID # 2020.KB.SAG.069
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date December 1, 2021

Study information

Verified date February 2024
Source Dokuz Eylul University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this randomized controlled study is to evaluate the effect of the mobile lymphedema self-care support program on self-care, quality of life and symptoms related to lymphedema in women with breast cancer-related lymphedema. H1: There is a difference between the Lymphedema Self-Care Scale mean score in women who develop lymphedema due to breast cancer, according to the use of the mobile lymphedema self-care support program. H2: There is a difference between the Lymphedema Quality of Life Scale average score in women who develop lymphedema due to breast cancer according to the status of using the mobile lymphedema self-care support program. H4: There is a difference between lymphedema arm circumference measurements according to the use of the mobile lymphedema self-care support program in women who develop lymphedema due to breast cancer. H5: In women who develop lymphedema due to breast cancer, there is a difference in the situation of experiencing symptoms related to lymphedema according to the use of the mobile lymphedema self-care support program.


Description:

The content of the mobile program was developed by the researchers. The mobile lymphedema self-care support program content was reviewed by an expert group consisting of doctors, physiotherapists and nurses working with patients with lymphedema. Patients will be contacted via telephone and will be informed about the study, and the experimental and control groups will be selected through the randomization program among the patients who agree to participate in the study and meet the sampling inclusion criteria. Patients were blinded, and blindness will be achieved in the data analysing stage. All measurements will be made to the experimental and control groups at the same time. The standard lymphedema self-care training will be given to the experimental and the control group. And the experimental group will be educated on how to use the mobile program. When the study is completed, the control group will also be allowed to use the mobile program.


Recruitment information / eligibility

Status Completed
Enrollment 98
Est. completion date December 1, 2021
Est. primary completion date December 1, 2021
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 55 Years
Eligibility Inclusion Criteria: - diagnosed as breast cancer-related lymphedema - literate, - having a smart phone, - completed breast cancer treatment at least six months ago - volunteering to participate in the study Exclusion Criteria: - having morbid obesity - having metastazis - having dementia - having other psychiatric conditions - another health problem that could prevent to exercise - not using smart phone

Study Design


Intervention

Other:
Mobile Lymphedema Self-Care Support Program
The Mobile Lymphedema Self-Care Support Program is composed of three section. First section includes the information about lymphedema and lymphedema self care. Second section includes the exercises videos which women can concurrently exercise with application and an alarm to remind to exercise. Last section is a social network form the women could chat and share anything with eachother. Patients will be told how to use the Mobile Lymphedema Self-Care Support Program and a contact number will be provided to ask questions about the program at any time.
standart lymphedema education
The control group will receive standard lymphedema education. The standard lymphedema education is an online education composed of information about lymphedema and lymphedema self-care.

Locations

Country Name City State
Turkey Ege Universitesi, Lymphedema unit of Physical therapy and rehabilitation department Izmir Bornova

Sponsors (1)

Lead Sponsor Collaborator
Dokuz Eylul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Breast Cancer Related Lymphedema Self-Care Scale Score The Breast Related Lymphedema Self-Care Scale is valid and reliable tool. The lowest score is 31, the highest score is 124. Higher scores indicate better self-care. baseline, 1 month, 3 month
Primary Change in Quality of Life Measure for Limb Lymphedema-Arm Scale Score The Quality of Life Measure for Limb Lymphedema-Arm Scale was translated and cross-culturally adapted to Turkish. The highest score of the scale is 80 and the lowest score is 20. A high score indicates poor quality of life. baseline, 1 month, 3 month
Primary Change in Lymphedema Symptom Intensity and Distress Survey Score The Turkish version of Lymphedema Symptom Intensity and Distress Survey is valid and reliable. The highest score of the scale is 30 and the lowest score is zero. A high score means experiencing too many symptoms. baseline, 1 month, 3 month
Secondary Change in Arm circumferences Circumferential measurements are taken at the metacarpal joint, wrist, elbow, 10 cm below and 10 cm above the elbow. baseline, 1 month, 3 month
See also
  Status Clinical Trial Phase
Completed NCT06065423 - Evaluation of Home Program and Telerehabilitation for the Treatment Process in Patients With Breast Cancer-Related Lymphedema N/A
Recruiting NCT05682885 - The Effectiveness of Lymphatic Bypass Supermicrosurgery N/A
Recruiting NCT04824378 - Study on Classification Method of Indocyanine Green Lymphography Based on Deep Learning
Active, not recruiting NCT04872738 - Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment
Completed NCT05776433 - The Effects of Upper Extremity Lymphedema on Posture, Upper Extremity Functions, and Quality of Life
Active, not recruiting NCT05022823 - Exercise and Compression for Lymphedema N/A
Recruiting NCT04446494 - Identification and Preservation of Arm Lymphatics N/A
Completed NCT04881604 - Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema N/A
Recruiting NCT04934098 - Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema N/A
Enrolling by invitation NCT04165512 - Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema N/A
Terminated NCT04073823 - A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients N/A
Not yet recruiting NCT06182046 - Effect of BOSU Exercises Added to Complete Decongestive Treatment on Balance in Breast Cancer-associated Lymphedema. N/A
Recruiting NCT04690439 - Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema N/A
Recruiting NCT04665882 - Nomogram to Predict Breast Cancer Related Lymphedema N/A
Completed NCT04659564 - Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study N/A